Nicholas Stence
Concepts (299)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Stroke | 19 | 2023 | 1063 | 3.590 |
Why?
| Magnetic Resonance Imaging | 35 | 2025 | 3371 | 2.420 |
Why?
| Neuroimaging | 10 | 2024 | 278 | 1.980 |
Why?
| Brain Ischemia | 4 | 2022 | 305 | 1.780 |
Why?
| Brain | 17 | 2024 | 2615 | 1.280 |
Why?
| Magnetic Resonance Angiography | 4 | 2022 | 235 | 1.130 |
Why?
| Hyperglycinemia, Nonketotic | 3 | 2023 | 51 | 1.000 |
Why?
| Vertebral Artery Dissection | 2 | 2022 | 24 | 0.940 |
Why?
| Child | 49 | 2025 | 20636 | 0.850 |
Why?
| Tomography, X-Ray Computed | 11 | 2023 | 2509 | 0.810 |
Why?
| Infarction, Middle Cerebral Artery | 2 | 2022 | 36 | 0.810 |
Why?
| Intracranial Arterial Diseases | 2 | 2024 | 8 | 0.800 |
Why?
| Craniocerebral Trauma | 5 | 2025 | 151 | 0.800 |
Why?
| White Matter | 3 | 2023 | 133 | 0.780 |
Why?
| Cerebral Arteries | 2 | 2024 | 57 | 0.770 |
Why?
| Intracranial Aneurysm | 1 | 2022 | 94 | 0.730 |
Why?
| Cerebral Arterial Diseases | 4 | 2025 | 44 | 0.720 |
Why?
| Child Abuse | 6 | 2025 | 517 | 0.710 |
Why?
| Child, Preschool | 34 | 2025 | 10378 | 0.680 |
Why?
| Corpus Callosum | 2 | 2023 | 66 | 0.670 |
Why?
| Brain Infarction | 2 | 2018 | 22 | 0.660 |
Why?
| Retrospective Studies | 27 | 2025 | 14404 | 0.600 |
Why?
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2019 | 96 | 0.590 |
Why?
| Infant | 31 | 2025 | 8912 | 0.590 |
Why?
| Infant, Newborn, Diseases | 2 | 2019 | 108 | 0.580 |
Why?
| Head | 1 | 2019 | 96 | 0.580 |
Why?
| Radiation Dosage | 1 | 2019 | 151 | 0.570 |
Why?
| Hippocampus | 2 | 2018 | 801 | 0.560 |
Why?
| Venous Thrombosis | 2 | 2016 | 161 | 0.550 |
Why?
| Intracranial Thrombosis | 2 | 2016 | 16 | 0.540 |
Why?
| Humans | 78 | 2025 | 128019 | 0.510 |
Why?
| Cerebral Veins | 1 | 2016 | 15 | 0.510 |
Why?
| Cranial Nerve Diseases | 1 | 2014 | 41 | 0.460 |
Why?
| Paraplegia | 1 | 2014 | 56 | 0.460 |
Why?
| Image Interpretation, Computer-Assisted | 2 | 2016 | 253 | 0.450 |
Why?
| Adolescent | 25 | 2025 | 20158 | 0.450 |
Why?
| Pediatrics | 3 | 2019 | 1044 | 0.450 |
Why?
| Infant, Newborn | 15 | 2025 | 5688 | 0.440 |
Why?
| Brain Injuries, Traumatic | 3 | 2025 | 337 | 0.430 |
Why?
| Female | 47 | 2025 | 68016 | 0.420 |
Why?
| Metal Metabolism, Inborn Errors | 1 | 2012 | 5 | 0.410 |
Why?
| Enterovirus D, Human | 1 | 2014 | 82 | 0.410 |
Why?
| Megalencephaly | 2 | 2023 | 19 | 0.410 |
Why?
| Disease Progression | 4 | 2020 | 2598 | 0.400 |
Why?
| Diffusion Magnetic Resonance Imaging | 1 | 2012 | 96 | 0.390 |
Why?
| Enterovirus Infections | 1 | 2014 | 171 | 0.380 |
Why?
| Male | 43 | 2025 | 62757 | 0.380 |
Why?
| Spinal Injuries | 2 | 2024 | 52 | 0.370 |
Why?
| Diet, Ketogenic | 2 | 2022 | 35 | 0.360 |
Why?
| Hypoxia-Ischemia, Brain | 2 | 2024 | 31 | 0.350 |
Why?
| Brain Neoplasms | 5 | 2020 | 1163 | 0.350 |
Why?
| Craniosynostoses | 2 | 2023 | 33 | 0.330 |
Why?
| Cerebral Cortex | 1 | 2012 | 422 | 0.320 |
Why?
| Craniopharyngioma | 2 | 2020 | 82 | 0.310 |
Why?
| Drug Resistant Epilepsy | 2 | 2021 | 83 | 0.300 |
Why?
| Hydrocephalus | 2 | 2020 | 108 | 0.290 |
Why?
| Cerebrovascular Disorders | 2 | 2022 | 89 | 0.290 |
Why?
| Temporal Lobe | 2 | 2019 | 85 | 0.280 |
Why?
| Neural Tube Defects | 2 | 2018 | 63 | 0.270 |
Why?
| Cerebral Angiography | 2 | 2024 | 109 | 0.270 |
Why?
| Imaging, Three-Dimensional | 3 | 2020 | 529 | 0.260 |
Why?
| Radiography | 3 | 2017 | 794 | 0.250 |
Why?
| Sensitivity and Specificity | 2 | 2024 | 1813 | 0.250 |
Why?
| Thrombectomy | 2 | 2022 | 59 | 0.250 |
Why?
| Middle Cerebral Artery | 2 | 2022 | 42 | 0.240 |
Why?
| Brain Edema | 1 | 2025 | 60 | 0.230 |
Why?
| Electroencephalography | 3 | 2021 | 396 | 0.220 |
Why?
| Prenatal Diagnosis | 2 | 2022 | 190 | 0.220 |
Why?
| Polymicrogyria | 1 | 2023 | 6 | 0.220 |
Why?
| Craniotomy | 2 | 2015 | 68 | 0.210 |
Why?
| Cervical Vertebrae | 1 | 2024 | 132 | 0.200 |
Why?
| Perfusion Imaging | 1 | 2022 | 56 | 0.200 |
Why?
| Neurodevelopmental Disorders | 1 | 2025 | 155 | 0.200 |
Why?
| Recurrence | 3 | 2022 | 993 | 0.200 |
Why?
| Intracranial Hemorrhages | 2 | 2019 | 79 | 0.200 |
Why?
| Circle of Willis | 1 | 2022 | 8 | 0.200 |
Why?
| Vertebral Artery | 1 | 2022 | 25 | 0.190 |
Why?
| Perfusion | 1 | 2022 | 188 | 0.190 |
Why?
| Migraine Disorders | 1 | 2023 | 83 | 0.190 |
Why?
| Adrenal Cortex Hormones | 1 | 2025 | 518 | 0.190 |
Why?
| Fetal Diseases | 1 | 2022 | 156 | 0.190 |
Why?
| Intracranial Hemorrhage, Traumatic | 1 | 2021 | 8 | 0.180 |
Why?
| Spectroscopy, Near-Infrared | 1 | 2021 | 48 | 0.180 |
Why?
| Point-of-Care Testing | 1 | 2021 | 32 | 0.180 |
Why?
| Fetus | 2 | 2022 | 760 | 0.180 |
Why?
| Brain Abscess | 1 | 2020 | 10 | 0.170 |
Why?
| Urinary Bladder | 1 | 2022 | 175 | 0.170 |
Why?
| Esophageal Perforation | 1 | 2020 | 15 | 0.170 |
Why?
| Esophageal Fistula | 1 | 2020 | 18 | 0.170 |
Why?
| Leukodystrophy, Globoid Cell | 1 | 2020 | 8 | 0.170 |
Why?
| Nervous System Malformations | 1 | 2020 | 37 | 0.170 |
Why?
| Gadolinium DTPA | 2 | 2019 | 49 | 0.170 |
Why?
| Follow-Up Studies | 4 | 2017 | 4853 | 0.170 |
Why?
| Semicircular Canals | 1 | 2020 | 29 | 0.170 |
Why?
| Pyruvate Dehydrogenase Complex Deficiency Disease | 1 | 2019 | 6 | 0.170 |
Why?
| Diagnosis, Computer-Assisted | 1 | 2020 | 87 | 0.170 |
Why?
| Microscopy, Confocal | 1 | 2001 | 307 | 0.170 |
Why?
| Carotid Artery Diseases | 1 | 2019 | 64 | 0.160 |
Why?
| Image Processing, Computer-Assisted | 2 | 2020 | 734 | 0.160 |
Why?
| Neck | 1 | 2019 | 92 | 0.160 |
Why?
| Optic Nerve Neoplasms | 1 | 2019 | 12 | 0.160 |
Why?
| Optic Chiasm | 1 | 2019 | 19 | 0.160 |
Why?
| Foreign Bodies | 1 | 2020 | 101 | 0.160 |
Why?
| Cohort Studies | 6 | 2025 | 5378 | 0.160 |
Why?
| Gray Matter | 1 | 2019 | 82 | 0.160 |
Why?
| Thrombosis | 1 | 2022 | 323 | 0.160 |
Why?
| Lymphohistiocytosis, Hemophagocytic | 1 | 2019 | 28 | 0.150 |
Why?
| Signal-To-Noise Ratio | 1 | 2019 | 68 | 0.150 |
Why?
| Wounds, Nonpenetrating | 3 | 2024 | 271 | 0.150 |
Why?
| Microglia | 1 | 2001 | 228 | 0.150 |
Why?
| Anatomic Landmarks | 1 | 2018 | 28 | 0.150 |
Why?
| Spectrum Analysis | 1 | 2019 | 86 | 0.150 |
Why?
| Carotid Stenosis | 2 | 2018 | 85 | 0.150 |
Why?
| Occipital Bone | 1 | 2018 | 18 | 0.150 |
Why?
| Sphenoid Bone | 1 | 2018 | 15 | 0.150 |
Why?
| Skull Base | 1 | 2018 | 43 | 0.150 |
Why?
| Autism Spectrum Disorder | 1 | 2023 | 385 | 0.150 |
Why?
| Age Determination by Skeleton | 1 | 2017 | 18 | 0.140 |
Why?
| Adult | 10 | 2023 | 35176 | 0.140 |
Why?
| Critical Illness | 1 | 2023 | 755 | 0.140 |
Why?
| Occipital Lobe | 1 | 2017 | 24 | 0.140 |
Why?
| Treatment Outcome | 7 | 2022 | 10110 | 0.140 |
Why?
| Adenoidectomy | 1 | 2018 | 66 | 0.140 |
Why?
| Epilepsies, Partial | 1 | 2018 | 46 | 0.140 |
Why?
| Lumbar Vertebrae | 2 | 2016 | 230 | 0.140 |
Why?
| Scoliosis | 1 | 2020 | 201 | 0.140 |
Why?
| Cerebrospinal Fluid Shunts | 1 | 2017 | 32 | 0.140 |
Why?
| Fluorodeoxyglucose F18 | 1 | 2018 | 127 | 0.140 |
Why?
| Pregnancy | 4 | 2022 | 6355 | 0.140 |
Why?
| Disease Management | 2 | 2025 | 583 | 0.140 |
Why?
| Pituitary Neoplasms | 1 | 2019 | 183 | 0.140 |
Why?
| Seizures | 2 | 2017 | 400 | 0.140 |
Why?
| Prevalence | 5 | 2022 | 2541 | 0.140 |
Why?
| Predictive Value of Tests | 2 | 2024 | 1934 | 0.130 |
Why?
| Cerebral Hemorrhage | 1 | 2017 | 106 | 0.130 |
Why?
| Positron-Emission Tomography | 1 | 2018 | 283 | 0.130 |
Why?
| Spondylolysis | 1 | 2016 | 7 | 0.130 |
Why?
| Glasgow Coma Scale | 3 | 2025 | 167 | 0.130 |
Why?
| Cell Movement | 1 | 2001 | 933 | 0.130 |
Why?
| Frontal Lobe | 1 | 2017 | 153 | 0.130 |
Why?
| Postoperative Complications | 2 | 2018 | 2456 | 0.130 |
Why?
| Hand | 1 | 2017 | 153 | 0.130 |
Why?
| Acute Kidney Injury | 1 | 2024 | 777 | 0.130 |
Why?
| Spinal Cord | 1 | 2018 | 353 | 0.130 |
Why?
| Osteomyelitis | 1 | 2018 | 123 | 0.130 |
Why?
| Tissue Adhesions | 1 | 2015 | 31 | 0.130 |
Why?
| Cranial Fossa, Posterior | 1 | 2015 | 17 | 0.130 |
Why?
| Overweight | 1 | 2020 | 522 | 0.130 |
Why?
| Supratentorial Neoplasms | 1 | 2015 | 19 | 0.120 |
Why?
| Cavernous Sinus Thrombosis | 1 | 2015 | 9 | 0.120 |
Why?
| Ganglioglioma | 1 | 2015 | 31 | 0.120 |
Why?
| Cerebral Infarction | 1 | 2015 | 42 | 0.120 |
Why?
| Arnold-Chiari Malformation | 1 | 2015 | 31 | 0.120 |
Why?
| Brain Diseases | 1 | 2016 | 136 | 0.120 |
Why?
| Central Nervous System Diseases | 1 | 2015 | 67 | 0.120 |
Why?
| Hypothalamus | 1 | 2015 | 144 | 0.120 |
Why?
| Thrombolytic Therapy | 1 | 2015 | 131 | 0.120 |
Why?
| Brain Stem Neoplasms | 1 | 2015 | 89 | 0.120 |
Why?
| Reproducibility of Results | 3 | 2019 | 3009 | 0.110 |
Why?
| United States | 4 | 2022 | 13785 | 0.110 |
Why?
| Brain Stem | 1 | 2014 | 98 | 0.110 |
Why?
| Neoplasms, Radiation-Induced | 1 | 2014 | 71 | 0.110 |
Why?
| Glipizide | 1 | 2013 | 6 | 0.110 |
Why?
| Cerebellum | 1 | 2015 | 217 | 0.110 |
Why?
| Neurofibromatosis 1 | 1 | 2014 | 45 | 0.110 |
Why?
| Age Factors | 2 | 2018 | 3100 | 0.110 |
Why?
| Guanine Nucleotide Exchange Factors | 1 | 2014 | 63 | 0.110 |
Why?
| Contrast Media | 1 | 2016 | 387 | 0.110 |
Why?
| Databases, Factual | 1 | 2019 | 1264 | 0.110 |
Why?
| Octreotide | 1 | 2013 | 27 | 0.110 |
Why?
| Sulfonylurea Compounds | 1 | 2013 | 46 | 0.100 |
Why?
| Molybdoferredoxin | 1 | 2012 | 12 | 0.100 |
Why?
| Biomarkers | 1 | 2024 | 3874 | 0.100 |
Why?
| Machine Learning | 1 | 2017 | 442 | 0.100 |
Why?
| Risk Factors | 3 | 2022 | 9696 | 0.100 |
Why?
| Fibrin Fibrinogen Degradation Products | 1 | 2012 | 78 | 0.100 |
Why?
| Migraine with Aura | 1 | 2012 | 6 | 0.100 |
Why?
| Cross-Sectional Studies | 2 | 2023 | 5034 | 0.100 |
Why?
| Radiation Injuries | 1 | 2013 | 135 | 0.100 |
Why?
| Glycine | 2 | 2023 | 163 | 0.100 |
Why?
| Accidents | 1 | 2012 | 39 | 0.090 |
Why?
| Ependymoma | 1 | 2014 | 176 | 0.090 |
Why?
| Disease Outbreaks | 1 | 2014 | 339 | 0.090 |
Why?
| Hematoma, Subdural | 2 | 2022 | 17 | 0.090 |
Why?
| Prognosis | 4 | 2023 | 3766 | 0.090 |
Why?
| Decompression, Surgical | 1 | 2012 | 99 | 0.090 |
Why?
| Edema | 1 | 2012 | 120 | 0.090 |
Why?
| Brain Injuries | 2 | 2015 | 463 | 0.090 |
Why?
| Blood Coagulation Disorders | 1 | 2012 | 162 | 0.090 |
Why?
| Anticoagulants | 1 | 2015 | 615 | 0.090 |
Why?
| Radiosurgery | 1 | 2014 | 318 | 0.090 |
Why?
| Biomedical Research | 1 | 2017 | 632 | 0.090 |
Why?
| Phenotype | 1 | 2019 | 3039 | 0.090 |
Why?
| Fibrinolytic Agents | 1 | 2012 | 248 | 0.090 |
Why?
| Herpesvirus 3, Human | 1 | 2014 | 330 | 0.080 |
Why?
| Glioma | 1 | 2014 | 353 | 0.080 |
Why?
| Herpes Zoster | 1 | 2014 | 317 | 0.080 |
Why?
| Emergency Medical Services | 1 | 2015 | 518 | 0.080 |
Why?
| Hypoglycemia | 1 | 2013 | 425 | 0.080 |
Why?
| Neoplasm Recurrence, Local | 1 | 2014 | 955 | 0.070 |
Why?
| Multivariate Analysis | 2 | 2024 | 1492 | 0.070 |
Why?
| Obesity | 1 | 2020 | 2859 | 0.070 |
Why?
| Prospective Studies | 3 | 2025 | 7035 | 0.070 |
Why?
| Anesthesia, General | 1 | 2024 | 49 | 0.060 |
Why?
| Hepatitis A Virus Cellular Receptor 1 | 1 | 2024 | 42 | 0.060 |
Why?
| Diffuse Axonal Injury | 1 | 2023 | 8 | 0.060 |
Why?
| Multicenter Studies as Topic | 1 | 2025 | 285 | 0.060 |
Why?
| Feasibility Studies | 2 | 2019 | 860 | 0.050 |
Why?
| Lipocalin-2 | 1 | 2024 | 75 | 0.050 |
Why?
| Cranial Sutures | 1 | 2023 | 9 | 0.050 |
Why?
| Hypothermia, Induced | 1 | 2024 | 73 | 0.050 |
Why?
| Sutures | 1 | 2023 | 52 | 0.050 |
Why?
| Benzoates | 1 | 2022 | 41 | 0.050 |
Why?
| Injury Severity Score | 1 | 2025 | 509 | 0.050 |
Why?
| Duodenum | 1 | 2022 | 71 | 0.050 |
Why?
| Interleukin-18 | 1 | 2024 | 236 | 0.050 |
Why?
| Headache | 1 | 2023 | 137 | 0.050 |
Why?
| PTEN Phosphohydrolase | 1 | 2023 | 157 | 0.050 |
Why?
| Mutation | 3 | 2023 | 3682 | 0.050 |
Why?
| Muscle, Smooth | 1 | 2022 | 152 | 0.050 |
Why?
| Subdural Space | 1 | 2021 | 7 | 0.050 |
Why?
| Exons | 1 | 2023 | 338 | 0.050 |
Why?
| Stereotaxic Techniques | 1 | 2021 | 38 | 0.050 |
Why?
| Middle Aged | 2 | 2019 | 30812 | 0.050 |
Why?
| Microscopy, Video | 1 | 2001 | 25 | 0.050 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2023 | 356 | 0.050 |
Why?
| Surveys and Questionnaires | 2 | 2024 | 5353 | 0.040 |
Why?
| Electrodes, Implanted | 1 | 2021 | 104 | 0.040 |
Why?
| Organ Culture Techniques | 1 | 2001 | 145 | 0.040 |
Why?
| Maternal Inheritance | 1 | 2020 | 15 | 0.040 |
Why?
| Aged | 1 | 2019 | 21892 | 0.040 |
Why?
| Actins | 1 | 2022 | 401 | 0.040 |
Why?
| Patient Compliance | 1 | 2024 | 558 | 0.040 |
Why?
| Clinical Trials as Topic | 1 | 2025 | 997 | 0.040 |
Why?
| Preoperative Period | 1 | 2020 | 113 | 0.040 |
Why?
| Severity of Illness Index | 2 | 2018 | 2703 | 0.040 |
Why?
| Prenatal Care | 1 | 2022 | 274 | 0.040 |
Why?
| Young Adult | 4 | 2017 | 12281 | 0.040 |
Why?
| Diagnosis, Differential | 2 | 2015 | 1408 | 0.040 |
Why?
| Skull Fractures | 1 | 2019 | 33 | 0.040 |
Why?
| Gestational Age | 1 | 2022 | 868 | 0.040 |
Why?
| Radiation Exposure | 1 | 2019 | 45 | 0.040 |
Why?
| Anterior Cerebral Artery | 1 | 2018 | 5 | 0.040 |
Why?
| Posterior Cerebral Artery | 1 | 2018 | 6 | 0.040 |
Why?
| Foramen Magnum | 1 | 2018 | 8 | 0.040 |
Why?
| Ilium | 1 | 2018 | 29 | 0.040 |
Why?
| Ultrasonography, Prenatal | 1 | 2020 | 270 | 0.040 |
Why?
| Carotid Artery, Internal | 1 | 2018 | 41 | 0.040 |
Why?
| Hemispherectomy | 1 | 2018 | 3 | 0.040 |
Why?
| Area Under Curve | 1 | 2018 | 288 | 0.040 |
Why?
| Reference Values | 1 | 2019 | 776 | 0.040 |
Why?
| Computed Tomography Angiography | 1 | 2018 | 115 | 0.040 |
Why?
| Proteins | 1 | 2023 | 933 | 0.030 |
Why?
| ROC Curve | 1 | 2018 | 500 | 0.030 |
Why?
| Time Factors | 2 | 2019 | 6479 | 0.030 |
Why?
| Models, Theoretical | 1 | 2020 | 541 | 0.030 |
Why?
| Trauma Centers | 1 | 2019 | 400 | 0.030 |
Why?
| Proteomics | 1 | 2023 | 1008 | 0.030 |
Why?
| Tertiary Care Centers | 1 | 2017 | 146 | 0.030 |
Why?
| Organ Size | 1 | 2017 | 440 | 0.030 |
Why?
| Quality Improvement | 1 | 2024 | 1093 | 0.030 |
Why?
| Registries | 1 | 2023 | 1873 | 0.030 |
Why?
| Third Ventricle | 1 | 2015 | 17 | 0.030 |
Why?
| Hypothalamic Diseases | 1 | 2015 | 18 | 0.030 |
Why?
| Hamartoma | 1 | 2015 | 20 | 0.030 |
Why?
| Endocrine System Diseases | 1 | 2015 | 33 | 0.030 |
Why?
| Florida | 1 | 2015 | 92 | 0.030 |
Why?
| Central Nervous System Infections | 1 | 2015 | 35 | 0.030 |
Why?
| Endpoint Determination | 1 | 2015 | 75 | 0.030 |
Why?
| Emergencies | 1 | 2015 | 154 | 0.030 |
Why?
| Single-Blind Method | 1 | 2015 | 267 | 0.030 |
Why?
| Observer Variation | 1 | 2015 | 310 | 0.030 |
Why?
| Colorado | 2 | 2015 | 4369 | 0.030 |
Why?
| Pandemics | 1 | 2022 | 1473 | 0.030 |
Why?
| Quality Assurance, Health Care | 1 | 2015 | 315 | 0.030 |
Why?
| Algorithms | 1 | 2020 | 1609 | 0.030 |
Why?
| Critical Care | 1 | 2017 | 550 | 0.030 |
Why?
| DNA Mutational Analysis | 1 | 2014 | 384 | 0.030 |
Why?
| Developmental Disabilities | 1 | 2015 | 258 | 0.030 |
Why?
| Diagnostic Imaging | 1 | 2015 | 329 | 0.030 |
Why?
| Rats | 1 | 2001 | 5199 | 0.020 |
Why?
| Infusions, Intravenous | 1 | 2013 | 390 | 0.020 |
Why?
| Necrosis | 1 | 2013 | 228 | 0.020 |
Why?
| Biomechanical Phenomena | 1 | 2015 | 758 | 0.020 |
Why?
| Persistent Vegetative State | 1 | 2012 | 4 | 0.020 |
Why?
| Logistic Models | 1 | 2017 | 1975 | 0.020 |
Why?
| Kaplan-Meier Estimate | 1 | 2014 | 851 | 0.020 |
Why?
| Quality of Life | 1 | 2023 | 2672 | 0.020 |
Why?
| Disabled Children | 1 | 2012 | 66 | 0.020 |
Why?
| Hemorrhage | 1 | 2015 | 643 | 0.020 |
Why?
| Case-Control Studies | 1 | 2018 | 3324 | 0.020 |
Why?
| Incidence | 1 | 2017 | 2614 | 0.020 |
Why?
| Accidents, Traffic | 1 | 2012 | 186 | 0.020 |
Why?
| Pilot Projects | 1 | 2015 | 1559 | 0.020 |
Why?
| Emergency Service, Hospital | 1 | 2021 | 1896 | 0.020 |
Why?
| Research Design | 1 | 2015 | 1034 | 0.020 |
Why?
| Recovery of Function | 1 | 2012 | 630 | 0.020 |
Why?
| Animals | 2 | 2017 | 34487 | 0.020 |
Why?
| Athletic Injuries | 1 | 2012 | 506 | 0.020 |
Why?
|
|
Stence's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|